{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:26:55Z","timestamp":1790519215769,"version":"4.1.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1P50AR060780"],"award-info":[{"award-number":["1P50AR060780"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02191","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T04:31:01Z","timestamp":1538368261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":79,"title":["Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin"],"prefix":"10.3389","volume":"9","author":[{"given":"Sokratis A.","family":"Apostolidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Stifano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Tabib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Kahaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lafyatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/BOR.0000000000000112","article-title":"Endothelial dysfunction in systemic sclerosis","volume":"26","author":"Altorok","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"B3","first-page":"155","article-title":"Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis","volume":"27","author":"Cutolo","year":"2000","journal-title":"J Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am J Med"},{"key":"B5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","article-title":"Vascular disease in progressive systemic sclerosis (scleroderma)","volume":"73","author":"Norton","year":"1970","journal-title":"Ann Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rdc.2007.12.004","article-title":"Vascular disease in scleroderma: mechanisms of vascular injury","volume":"34","author":"Kahaleh","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"B8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12016-008-8106-x","article-title":"Vascular disease in scleroderma","volume":"36","author":"Wigley","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/art.38326","article-title":"Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis","volume":"66","author":"Kuwana","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.37705","article-title":"Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)\/transforming growth factor beta-dependent mesenchymal-to-mesenchymal transition","volume":"65","author":"Serrati","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van","year":"2014","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/art.21894","article-title":"Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts","volume":"54","author":"Gardner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2696","DOI":"10.1371\/annotation\/05bed72c-c6f6-4685-a732-02c78e5f66c2","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"B21","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"B22","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF02634257","article-title":"A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin","volume":"31","author":"Normand","year":"1995","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nprot.2014.006","article-title":"Full-length RNA-seq from single cells using Smart-seq2","volume":"9","author":"Picelli","year":"2014","journal-title":"Nat Protoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4.22.1","DOI":"10.1002\/0471142727.mb0422s107","article-title":"Preparation of single-cell RNA-seq libraries for next generation sequencing","author":"Trombetta","year":"2014","journal-title":"Curr Protoc Mol Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.ajpath.2016.06.020","article-title":"Altered dermal fibroblasts in systemic sclerosis display podoplanin and CD90","volume":"186","author":"Nazari","year":"2016","journal-title":"Am J Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/art.27220","article-title":"A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis","volume":"62","author":"Farina","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","article-title":"Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo","volume":"296","author":"Cox","year":"2006","journal-title":"Dev Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"Eyries","year":"2008","journal-title":"Circ Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/CIRCRESAHA.113.301324","article-title":"Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development","volume":"113","author":"Kang","year":"2013","journal-title":"Circ Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10456-013-9349-6","article-title":"Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis","volume":"16","author":"Kasai","year":"2013","journal-title":"Angiogenesis"},{"key":"B35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"Kasai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.3892\/mmr.2015.3866","article-title":"Apelin\/APJ signaling promotes hypoxia-induced proliferation of endothelial progenitor cells via phosphoinositide-3 kinase\/Akt signaling","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1755-1536-4-9","article-title":"Thrombospondin 1 is a key mediator of transforming growth factor beta-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)\/extracellular signal-regulated kinase (ERK)-dependent mechanism","volume":"4","author":"Chen","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B38","first-page":"2565","article-title":"Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation","volume":"29","author":"Macko","year":"2002","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0002-9440(10)62362-0","article-title":"Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts","volume":"166","author":"Mimura","year":"2005","journal-title":"Am J Pathol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/ar295","article-title":"Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)","volume":"3","author":"Scheja","year":"2001","journal-title":"Arthritis Res"},{"key":"B41","first-page":"5","article-title":"von Willebrand factor: increased levels are related to poor prognosis in systemic sclerosis and not to tissue autoantibodies","volume":"54","author":"Blann","year":"1997","journal-title":"Br J Biomed Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"482","DOI":"10.7326\/0003-4819-94-4-482","article-title":"Increased factor VIII\/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon","volume":"94","author":"Kahaleh","year":"1981","journal-title":"Ann Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e12106","DOI":"10.1371\/journal.pone.0012106","article-title":"Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury","volume":"5","author":"Pendergrass","year":"2010","journal-title":"PLoS ONE"},{"key":"B45","first-page":"1463","article-title":"Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells","volume":"148","author":"Gallai","year":"1996","journal-title":"Am J Pathol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jcb.24788","article-title":"Transcriptional activation by NFkappaB increases perlecan\/HSPG2 expression in the desmoplastic prostate tumor microenvironment","volume":"115","author":"Warren","year":"2014","journal-title":"J Cell Biochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0151736","DOI":"10.1371\/journal.pone.0151736","article-title":"Extracellular matrix molecular remodeling in human liver fibrosis evolution","volume":"11","author":"Baiocchini","year":"2016","journal-title":"PLoS ONE"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.4049\/jimmunol.174.9.5740","article-title":"Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis","volume":"174","author":"Laplante","year":"2005","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1158\/0008-5472.CAN-04-0810","article-title":"Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice","volume":"64","author":"Zhou","year":"2004","journal-title":"Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10735-016-9677-0","article-title":"The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-beta1 in skin compared to C57BL\/6 wild type mice","volume":"47","author":"Shu","year":"2016","journal-title":"J Mol Histol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1074\/jbc.272.8.5219","article-title":"Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element","volume":"272","author":"Iozzo","year":"1997","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1172\/JCI3793","article-title":"Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo","volume":"102","author":"Sharma","year":"1998","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","article-title":"Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis","volume":"42","author":"Rajkumar","year":"1999","journal-title":"Arthritis Rheum"},{"key":"B54","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar1963","article-title":"Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases","volume":"8","author":"Zvaifler","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/art.30317","article-title":"Protein kinase Cdelta and c-Abl kinase are required for transforming growth factor beta induction of endothelial-mesenchymal transition in vitro","volume":"63","author":"Li","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jb\/mvs071","article-title":"Biology of the apelin-APJ axis in vascular formation","volume":"152","author":"Kidoya","year":"2012","journal-title":"J Biochem"},{"key":"B57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.aam6607","article-title":"ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice","volume":"357","author":"Ho","year":"2017","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1468-3083.2011.04354.x","article-title":"Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis","volume":"27","author":"Aozasa","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCULATIONAHA.116.023218","article-title":"Elabela\/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension","volume":"135","author":"Yang","year":"2017","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4103\/2045-8932.87299","article-title":"Apelin and pulmonary hypertension","volume":"1","author":"Andersen","year":"2011","journal-title":"Pulm Circ"},{"key":"B62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ajpath.2011.09.035","article-title":"Apelin is required for non-neovascular remodeling in the retina","volume":"180","author":"McKenzie","year":"2012","journal-title":"Am J Pathol"},{"key":"B63","doi-asserted-by":"crossref","first-page":"22939","DOI":"10.1016\/S0021-9258(18)54445-8","article-title":"The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule","volume":"266","author":"Noonan","year":"1991","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02191\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T01:09:15Z","timestamp":1662167355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02191\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2018.02191"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02191","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"article-number":"2191"}}